Antibiotic resistance in most common childhood bacterial pathogens;Rezistencija na antibiotike najvažnijih bakterijskih patogena u dječjoj dobi

Paediatria Croatica, Supplement

Volumn 49, Issue 1, 2005, Pages 198-201

  Tambic Andrasevic, Arjana ^a  

^a Croatia   (Croatia)

Author keywords

Antibiotic resistance; Respiratory tract infections; Urinary tract infections

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; BETA LACTAMASE; CARBAPENEM; CEPHALOSPORIN; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONFERENCE PAPER; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; PRESCRIPTION; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; URINARY TRACT INFECTION;

EID: 37849028739     PISSN: 1330724X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Harwell JI, Brown RB. The drug-resistant pneumococcus. Clinical relevance, therapy, and prevention. Chest 2000; 117: 530-41.
2. Hansman D, Bullen MM. A resistant pneumococcus (letter). Lancet 1967; 2: 264-5.
3. Appelbaum PC, Bhamjee A, Scragg JN, Hallett AF, Bowen AJ, Cooper RC. Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet 1977; 2: 995-7.
4. Jacobs MR, Koornhof HJ. Robins-Browne RM, et al. Emergence of multiply resistant pneumococci. N Engl J Med 1978; 299: 735-40.
5. EARSS Annual Report 2003. Bilthoven: RIVM, 2004.
6. Musher DM. Streptococcus pneumoniae. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 5th ed. Philadelphia: Churchill Livingstone, 2000; 2128-47.
7. National Committee for Clinical Laboratory Standards (2000). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Supplement M100-S10. NCCLS, Wayne, PA.
8. Bryan CS, Talwani R, Stinson S. Penicillin dosing for pneumococcal pneumonia. Chest 1997; 99: 289-99.
9. Tambić T, Tambić Andrašević A. Praćenje rezistencije bakterija na antibiotike u RH. U: Tambić T, Tambić Andrašević A, ur. Osjetljivost i rezistencija bakterija na antibiotike u Republici Hrvatskoj u 2003.g. Zagreb: AMZH, 2004; 5-88.
10. Jacobs MR, Bajaksouzian S, Lin G, et al. Variation in antimicrobial resistance of community isolates of Streptococcus pneumoniae by age, region, and disease (abstract C-16). In: Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy; San Francisco, CA. Washington, DC: American Society for Microbiology, 1998.
11. Doern GV, Brueggemann AB, Blocker M, et al. Clonal relationships among high-level penicillin resistant Streptococcus pneumoniae in the United States. Clin Infect Dis 1991; 164: 302-6.
12. Munoz R, Coffey TJ, Daniels M, et al. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis 1991; 164: 302-6.
13. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: An overview. Clin Infect Dis 1992; 15: 77-83.
14. Tarasi A, Sterk-Kuzmanović N, Sieradzki K, Schoenwald S, Austrian R, Tomasz A. Penicillin-resistant and multidrug-resistant Streptococcus pneumoniae in a pediatric hospital in Zagreb, Croatia. Microbial Drug Resistance 1995; 1: 169-76.
15. Nagai K, Appelbaum PC, Davies TA, Kelly LM, Hoellman DB, Tambić Andrašević A, et al. Susceptibility to telithromycin and six other agents, and the incidence of L4 protein mutation in 992 Streptococcus pneumoniae from 10 central and eastern European centers. Clin Infect Dis (in the press).
16. Flemingham D, Gruenberg RN and the Alexander Project Group. The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community acquired lower respiratory tract infections. JAC 2000; 45: 191-203.
17. Leclerq R, Courvalin P. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob Agents Chemother 1991; 35: 1267-72.
18. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 1995; 39: 577-85.
19. Sutcliffe J, Tait-Karmadt A, Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern by an efflux system. Antimicrob Agents Chemother 1996; 40: 1817-24.
20. Steigbigel NH. Macrolides and Clindamycin. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 5th ed. Philadelphia: Churchill Livingstone, 2000; 366-82.
21. Tait-Kamardat A, Davies T, Jacobs MR, et al. Mutation in 23S rRNA and L4 ribosomal protein account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob Agents Chemother 2000; 44: 1894-99.
22. Pankuch GA, Bozdogan B, Nagai K, Tambić Andrašević A, Schoenwald S, Tambić T, Kalenić S, Pleško S, Tepeš N, Kotarski Z, Payerl Pal M, Appelbaum PC. Incidence, epidemiology and characteristics of quinolone-nonsusceptible S. pneumoniae in Croatia. Antimicrob Agents Chemother 2002; 46: 2671-5. Antimicrob Agents Chemother 2002; 46: 546-9.
23. Nagai K, Appelbaum PC, Davies TA, Kelly LM, Hoellman DB, Tambić Andrašević A, et al. Susceptibility of telithromycin against 1011 Streptococcus pyogenes isolated from 10 Central and Eastern European countries. Clin Infect Dis Antimicrob Agents Chemother 2002; 46: 546-9.
24. Doern GV, Bruggemann AB, Pierce G, Hogan T, Holley HP, Rauch A. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996; 40: 2884-6.
25. Livermore DM. Beta-lactamase-mediated resistance and opportunities for its control. J Antimicrob Chemoth 1998; 41 (supl. D): 25-41.
26. Livermore DM. Beta-lactamases in laboratory and clinical resistance. Clin Microbiol 1995; 8: 557-84.